Renaissance Capital logo

Centinel Spine Holdco

Filed, US Offering, NYSE: CNTL

Makes total disc replacement implants for the cervical and lumbar spine.

Industry: Health Care

We are a commercial-stage medical technology company with a singular mission to transform spine surgery by advancing motion-preserving solutions for the cervical and lumbar spine. We are exclusively focused on Total Disc Replacement (TDR), which we believe represents a fundamentally different and increasingly important approach to spine surgery compared to traditional fusion techniques that permanently eliminate motion. Our prodisc platform is designed to improve the long-term quality of life for patients suffering from chronic neck and back pain while preserving the spine’s natural movement. As a pure-play company dedicated solely to TDR, we believe our depth of experience, exclusive focus, and long history of clinical success uniquely position us to lead the continued evolution of spine surgery toward solutions designed to preserve motion. Spine disorders are among the most common medical conditions in the United States, with chronic neck and back pain affecting approximately 100 million people each year. Individuals living with degenerative disc disease (DDD) represent a significant subset of this population. Surgical intervention, including spinal fusion and total disc replacement, are commonly performed for patients with DDD. Despite its widespread use, spinal fusion has inherent clinical limitations that we believe can contribute to less favorable outcomes for many patients.
IPO Data
IPO File Date 10/07/2026
Offer Price n/a
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $100
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
Underwriter Name Morgan Stanley
Underwriter Name Goldman Sachs
more
Company Data
Headquarters West Chester, PA, United States
Founded 2008
Employees at IPO 138
Website www.centinelspine.com

Centinel Spine Holdco (CNTL) Performance